Emily Annika Burger

Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ.

J Med Screen. 2021 Mar 17. 9691413211001097. PMID: 33730899

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.

Kim JJ, Simms KT, Killen J, Smith MA, Burger EA, Sy S, Regan C, Canfell K.

PLoS Med. 2021 Mar. 18(3):e1003534. PMID: 33705382

Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.

Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA.

Prev Med. 2021 Mar. 144:106276. PMID: 33678239

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.

Fogelberg S, Clements MS, Pedersen K, Sy S, Sparén P, Kim JJ, Burger EA.

PLoS One. 2020. 15(9):e0239611. PMID: 32997696

Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.

Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms KT, Smith MA, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, Kim JJ.

J Natl Cancer Inst. 2020 09 01. 112(9):955-963. PMID: 31821501

Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.

Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ.

Int J Cancer. 2021 Feb 15. 148(4):932-940. PMID: 32706907

Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.

Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K.

Gynecol Oncol. 2020 09. 158(3):710-718. PMID: 32723676

The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology.

de Kok IMCM, Burger EA, Naber SK, Canfell K, Killen J, Simms K, Kulasingam S, Groene E, Sy S, Kim JJ, van Ballegooijen M.

Med Decis Making. 2020 05. 40(4):474-482. PMID: 32486894

Covid-19: Simulation models for epidemics.

Kristiansen IS, Burger EA, Blasio BF.

Tidsskr Nor Laegeforen. 2020 04 21. 140(6). PMID: 32321234

Projected time to elimination of cervical cancer in the USA: a comparative modelling study.

Burger EA, Smith MA, Killen J, Sy S, Simms KT, Canfell K, Kim JJ.

Lancet Public Health. 2020 04. 5(4):e213-e222. PMID: 32057315